HI
MBOT icon

Harbour Investments’s Microbot Medical MBOT Stock Holding History

Harbour Investments’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2 Hold
1
– – ﹤0.01% 4657
2025
Q4 		$2 Buy
+1
New +$2 ﹤0.01% 3854
2021
Q4 		– Sell
-1
Closed – – 3257
2021
Q3 		$0 Sell
1
-1
-50% -$7 ﹤0.01% 3879
2021
Q2 		$0 Hold
2
– – ﹤0.01% 3878
2021
Q1 		$0 Buy
+2
New +$17 ﹤0.01% 3669

Other funds holding MBOT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Harbour Investments's MBOT Position: Q1 2026 in Review

Harbour Investments held its Microbot Medical (MBOT) position steady in Q1 2026 at 1 share worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #4657.

Harbour Investments first reported a position in MBOT in Q1 2021 and has held it in 5 quarters since. 79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.

  • Harbour Investments held 1 share of Microbot Medical worth $2 as of Q1 2026.
  • Harbour Investments left its Microbot Medical share count unchanged in Q1 2026.
  • Microbot Medical made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #4657 holding.
  • Harbour Investments first reported a position in Microbot Medical in Q1 2021 and has held it in 5 quarters since.
  • 79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.